Basit öğe kaydını göster

dc.contributor.authorGuney, Murat
dc.contributor.authorCavdar, Huseyin
dc.contributor.authorSenturk, Murat
dc.contributor.authorEkinci, Deniz
dc.date.accessioned2020-06-21T13:45:43Z
dc.date.available2020-06-21T13:45:43Z
dc.date.issued2015
dc.identifier.issn0960-894X
dc.identifier.issn1464-3405
dc.identifier.urihttps://doi.org/10.1016/j.bmcl.2015.05.073
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14160
dc.descriptionSenturk, Murat/0000-0001-5968-7511en_US
dc.descriptionWOS: 000357572000037en_US
dc.descriptionPubMed: 26073005en_US
dc.description.abstractCarbonic anhydrase (CA) inhibitors are valuable molecules based on several therapeutic applications, including antiglaucoma activity. In the present study, inhibition of two human cytosolic carbonic anhydrase isozymes I and II with some uracil derivatives (3-9) were investigated. Compounds 3-9 showed K-I values in the range of 10.83-464 mu M for hCA I and of 28.88-778.5 mu M against hCA II, respectively. Kinetic investigations showed that similarly to classical CA inhibitors, all investigated natural compounds act as competitive inhibitors with 4-NPA as substrate. Uracil derivatives investigated here are promising agents which may be used as lead molecules in order to derivative novel carbonic anhydrase inhibitors that might be useful in medical applications. (C) 2015 Elsevier Ltd. All rights reserved.en_US
dc.description.sponsorshipAgri Ibrahim Cecen University Scientific Research CouncilAgri Ibrahim Cecen University [Agri BAP-2010/K-09]; TUBITAK (The Scientific and Technological Research Council of Turkey)Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK) [114Z731]en_US
dc.description.sponsorshipThis study was financed by Agri Ibrahim Cecen University Scientific Research Council, (project no: Agri BAP-2010/K-09) for (MG) and by TUBITAK (The Scientific and Technological Research Council of Turkey) (Project no: 114Z731) for (MS). The authors are grateful to Prof. Dr. Claudiu T. Supuran, University of Florence, for various valuable studies on carbonic anhydrase inhibitors.en_US
dc.language.isoengen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.isversionof10.1016/j.bmcl.2015.05.073en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCarbonic anhydraseen_US
dc.subjectHydroxylen_US
dc.subjectUracilen_US
dc.subjectEnzyme inhibitoren_US
dc.titleSynthesis and carbonic anhydrase inhibitory properties of novel uracil derivativesen_US
dc.typearticleen_US
dc.contributor.departmentOMÜen_US
dc.identifier.volume25en_US
dc.identifier.issue16en_US
dc.identifier.startpage3261en_US
dc.identifier.endpage3263en_US
dc.relation.journalBioorganic & Medicinal Chemistry Lettersen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster